Among these kinases, AMP-activated protein kinase (AMPK), a known regulator of energy metabolism and potent drug target for metabolic diseases, was predicted to be active in LFD-fed WAT in comparison to HFD-fed WAT. This evidence concerns the gene PRKAB1 and Other metabolic disease.